ArticleTargeted oncology2016

Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.

J Rolff et al.PubMed ↗Publisher ↗

No numbers read from the abstract.